Dahlia Life Science Medical Consulting

CMC IND/BLA Roadmap, Strategy
& Operational Readiness Assessment

(IND/BLA Roadmap, Strategy & Operational Readiness Assessment)

Interested in seeing what we can do for you? Call or email us to start the conversation.
  • Partner with client to develop Investigational New Drug (IND) / Biologics License Applications(BLA) / Computer-mediated communication(CMC) Roadmap (Module 2 and Module 3).
  • Assess operational readiness of: Investigational New Drug (IND) / Biologics License Applications(BLA).
  • Perform capability assessment to enable: Investigational New Drug (IND) / Biologics License Applications(BLA) / Personal Activity Intelligence(PAI).
  • Technical writing and authoring of: Investigational New Drug (IND) / Biologics License Applications(BLA).
RETURN
Dahlia Pharma Biotherapeutics Advisors Science

CMC IND/BLA Roadmap, Strategy
& Operational Readiness Assessment

(Environmental Monitoring Performance Qualification)
Assessment of facility processing environment to determine those areas that have the highest risks.
  • Partner with client to develop Investigational New Drug (IND) / Biologics License Applications(BLA) / Computer-mediated communication(CMC) Roadmap (Module 2 and Module 3).
  • Assess operational readiness of: Investigational New Drug (IND) / Biologics License Applications(BLA).
  • Perform capability assessment to enable: Investigational New Drug (IND) / Biologics License Applications(BLA) / Personal Activity Intelligence(PAI).
  • Technical writing and authoring of IND/BLA components.
RETURN
Dahlia Pharma Biotherapeutics Advisors Science